Taiwanese Pharmaceuticals & Biotech Most Popular Stocks

Intelligene

Market Cap: NT$7.0b

Engages in the research and development of RNA gene therapy drugs in Taiwan and Australia.

Acepodia

Market Cap: NT$7.0b

Operates as a clinical stage biotechnology company.

Savior Lifetec

Market Cap: NT$6.9b

Engages in the research, development, design, manufacture, and sale of carbapenem generics in the Americas, Asia, Taiwan, Europe, and internationally.

Alar Pharmaceuticals

Market Cap: NT$6.7b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

Uwell Biopharma

Market Cap: NT$6.7b

A clinical-stage biopharmaceutical company, engages in the development and commercialization of novel cancer immunotherapeutic in Taiwan.

Formosa Laboratories

Market Cap: NT$6.5b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

TaiGen Biopharmaceuticals Holdings

Market Cap: NT$6.4b

A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.

SCI Pharmtech

Market Cap: NT$6.3b

Engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals.

Sinphar PharmaceuticalLtd

Market Cap: NT$6.2b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

TWi Biotechnology

Market Cap: NT$5.5b

A clinical-stage biopharmaceutical company, develops and sells drugs for innate immunity-related diseases in Taiwan.

Orient Pharma

Market Cap: NT$5.4b

Engages in the development of new drugs in Taiwan and internationally.

Cenra

Market Cap: NT$5.4b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Tripartite Therapeutics

Market Cap: NT$5.3b

Engages in the development of proprietary platform technologies for targeted delivery of therapeutics in Taiwan.

AnnJi Pharmaceutical

Market Cap: NT$5.2b

Develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders.

Medigen Biotechnology

Market Cap: NT$5.2b

A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cell therapy, advanced nucleic acid testing, generic drugs, medical beauty, and vaccine-related products in Taiwan.

Steminent Biotherapeutics

Market Cap: NT$5.2b

Operates as a biopharmaceutical company in Taiwan and the United States.

Mycenax Biotech

Market Cap: NT$5.1b

Provides biopharmaceutical services and solutions for drug development and production in Taiwan.

Panion & Bf Biotech

Market Cap: NT$5.1b

A biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally.

UnicoCell Biomed

Market Cap: NT$4.6b

Engages in the research and development of stem cell drugs in Taiwan and Japan.

Pharmosa Biopharm

Market Cap: NT$4.2b

A biotechnology company, focuses on research and development of new drugs in Taiwan.

Orient EuroPharma

Market Cap: NT$4.2b

A pharmaceutical company, develops and manufactures drugs worldwide.

Sinew Pharma

Market Cap: NT$4.1b

A biopharmaceutical company, focuses on the research, development, and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

Tien Liang BioTech

Market Cap: NT$4.0b

Manufactures and sells pharmaceutical products in Taiwan.

Yoda Pharmaceuticals

Market Cap: NT$3.8b

An AI-driven company, focuses on development of drugs targeting central nervous system disorders.

Obigen Pharma

Market Cap: NT$3.8b

Engages in research, manufacturing, and promotion of biotechnology and novel botulinum toxin.

StemCyte International

Market Cap: NT$3.8b

A biotechnology company, develops cord blood–based cell therapies in the United States and Taiwan.

Easywell Biomedicals

Market Cap: NT$3.8b

Develops, manufactures, and sells generic pharmaceutical ingredients and products in America, China, and Taiwan.

Maxigen Biotech

Market Cap: NT$3.6b

Researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally.

SunWay Biotech

Market Cap: NT$3.6b

Focuses on professional research and development, and technical material manufacturing and processing business.

OBI Pharma

Market Cap: NT$3.5b

A clinical stage oncology company, researches and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally.

Formosa Pharmaceuticals

Market Cap: NT$3.5b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

BioGend Therapeutics

Market Cap: NT$3.5b

Engages in the research and development, and sale of orthopedic medical devices and related products.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

Nang Kuang Pharmaceutical

Market Cap: NT$3.2b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

Shine-On BioMedicalLtd

Market Cap: NT$3.1b

Research, develops, and manufactures anti-cancer related drug products.

Senhwa Biosciences

Market Cap: NT$3.1b

Engages in the development of novel drugs and special active pharmaceutical ingredients.